Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
72
天
Immunohistochemical Assay Variability and Human Epidermal Growth Factor Receptor 2 (HER2)-Low Breast Cancer Detection: A Laboratory Comparison in the Netherlands
作者
Zeynep E. Kain; Emma Schuurman; Ximena Baez-Navarro; Henrik Høeg; Prasanth Kanneganti; Nils ’t Hart; Carolien H.M. van Deurzen展开收起
作者单位
Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Pathology, Isala, Zwolle, the Netherlands; Visiopharm A/S, Hørsholm, Denmark; Boston Cell Standards Inc, Boston, Massachusetts展开收起
78
天
Paired Tissue and Circulating Tumor DNA Profiling Reveals Novel ESR1 Amplifications and CDK4/6 Inhibtor Resistance Mechanisms in Hormone Receptor–Positive/HER2–Negative Metastatic Breast Cancers
作者
Liu Liu; Stephanie L. Graff; Liang Cheng; Yihong Wang展开收起
作者单位
Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island; Division of Medical Oncology, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island展开收起
165
天
Cross-Platform Comparative Spatial Transcriptomics in High-Grade Serous Carcinoma
作者
Omar Youssef; Lars Selander; Shuyu Zheng; Lilla Csellar; Satu Hänninen; Jing Tang; Olli Carpén; Anna Ray Laury展开收起
作者单位
Department of Pathology, University of Helsinki, Helsinki, Finland; Clinical and Chemical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; KIGene Core Facility, Karolinska Institutet, Stockholm, Sweden; Helsinki Biobank, Helsinki, Finland; University of Helsinki and Helsinki University Hospital, Helsinki, Finland展开收起
161
天
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天